〰️
Congratulations to Kyle Vollett on his Int J Mol Sci publication (May 2023).
〰️
Congratulations to Aaron Curtis on his Scientific Reports publication (June 2023)
〰️
Congratulations to Prof. Cheng on her promotion to Full Professor (July 2023)
〰️
Congratulations to Dr. Sadi Loai on his successful PhD defense (August 2023).
〰️
Congratulations to Aaron Troy on his successful MASc defense (September 2023).
〰️
Congratulations to Sadi Loai on his Front Cardiovasc Med publication (November 2023).
〰️
Congratulations to Keyu Zhuang on her Stem Cell Res Ther publication (November 2023).
〰️
Congratulations to Aaron Troy on his AJP Heart & Circulatory Physiology publication (January 2024).
〰️
Congratulations to Keyu Zhuang on her Stem Cells Transl Med publication (January 2024).
〰️ Congratulations to Kyle Vollett on his Int J Mol Sci publication (May 2023). 〰️ Congratulations to Aaron Curtis on his Scientific Reports publication (June 2023) 〰️ Congratulations to Prof. Cheng on her promotion to Full Professor (July 2023) 〰️ Congratulations to Dr. Sadi Loai on his successful PhD defense (August 2023). 〰️ Congratulations to Aaron Troy on his successful MASc defense (September 2023). 〰️ Congratulations to Sadi Loai on his Front Cardiovasc Med publication (November 2023). 〰️ Congratulations to Keyu Zhuang on her Stem Cell Res Ther publication (November 2023). 〰️ Congratulations to Aaron Troy on his AJP Heart & Circulatory Physiology publication (January 2024). 〰️ Congratulations to Keyu Zhuang on her Stem Cells Transl Med publication (January 2024).
ABOUT US
Research in the Cheng laboratory is focused on the development of quantitative magnetic resonance imaging technology to enable advances in tissue engineering and other emerging therapies, and to achieve earlier detection of cardiovascular diseases and cancer than is currently possible. We take imaging beyond its role as an anatomical tool and advance it to probe physiological, cellular, and molecular events. An important philosophy at the heart of our research is translation to patients – hence, our emphasis on clinical platforms, rapid imaging, and safety. Our technology-driven program is intimately tied to biology-directed questions in in-vivo models to gain new insight into disease development and to develop better diagnostic and therapeutic tools.
